Sleep disorders Flashcards
(36 cards)
A) OSA
snoring, observed apnoeas, nocturnal choking and nocturia. Daytime sleepiness, or fatigue, is the most common daytime symptom with irritability or mood changes also commonly noted.
Examination
BMI, a crowded oropharynx (ie. large tonsils, a thick stumpy uvula and a large set back tongue), increased neck circumference
and retrognathia.
modified mallampati (MMP) score
neck circumference of greater than 40 cm-sensitivity of 60% and a specificity of 93% for OSA
Epworth Sleepiness Scale (ESS)
> 10/24 is considered abnormal
INV
investigations for OSA can be divided into four categories- in-laboratory polysomnography (PSG) undertaken with overnight observation, to a level four study, which consists of overnight pulse oximetry.
In-laboratory PSG is the gold standard for the diagnosis of OSA
RTA and driving
legal responsibility for notifying the relevant state or territory authority regarding medical conditions, which may affect driving, lies with
the driver once they are aware of the impact that their condition may have on driving. However, if there are concerns that the patient continues to drive despite appropriate advice and poses a public safety risk then direct reporting to the licensing authority should be considered.
there are statutes that may protect health professionals who report without patient consent from litigation
Confirmation
PSG occur at a frequency of >15 events/hour (also called the apnoea-hypopnoea index, or AHI) then a diagnosis of OSA is confirmed.
Rx
Treatment for OSA should be multimodal and include weight loss, exercise, avoidance of alcohol and sedatives and positional therapy
Return to work
sleep specialist may grant a conditional commercial licence after review where there has been a satisfactory response to treatment and the patient has demonstrated treatment compliance. Annual review is recommended.
B) NARCOLEPSY
four classic symptoms of narcolepsy are
excessive daytime sleepiness,
cataplexy (loss of msc tone),
sleep paralysis and hypnagogic (sleep onset) hallucinations.
Aeitiology
deficiency of the central
nervous system peptide hypocretin (also called orexin), which is a neurotransmitter that controls wakefulness and appetite
genetic factors involved
Diagnosis and inv
ESS and multiple sleep latency test (MSLT)
Diagnosis and inv
ESS and multiple sleep latency test (MSLT)
Diagnostic guidelines for narcolepsy require that the sleep/wake cycle has been assessed for at least 7 days prior
to PSG/MSLT with documentation such as a 7-day sleep diary and actigraphy. Actigraphy is a portable device that records movement over a prolonged period of time and provides information on sleep and waking times, as well as sleep duration and efficiency.
In the absence of cataplexy, to make a diagnosis of narcolepsy, a mean sleep latency of less than 8 minutes is required, with 2 or more sleep-onset REM periods
presence of HLA-DQB1*0602 and low CSF hypocretin are also supportive of a diagnosis of narcolepsy
Implications
Patients with narcolepsy should be advised to avoid occupations where there is the possibility of physical harm from inattentiveness or sleepiness
Advice regarding driving
advised not to drive until his symptoms are controlled
Not considered
fit to hold an unconditional driving licence
MX
no cure for narcolepsy
strict attention to sleep hygiene, naps prior to attention-intensive tasks, and avoidance of alcohol and carbohydrate rich meals
dexamphetamine is used as first line treatment.
Modafinil, a wakefulness-promoting agent, can be considered if there is a contraindication to dexamphetamine
Management of REM phenomena including cataplexy requires use
of serotonin-noradrenaline reuptake inhibitors Alternative medications include tricyclic antidepressants (clomipramine is considered the treatment of choice) and fluoxetine.31
C) RESTLESS LEG syd (RLS)
The essential criteria are:
• an urge to move the legs, usually accompanied by uncomfortable or unpleasant sensations in the legs
• the urge to move or unpleasant sensations usually begins during periods of rest or inactivity
• this urge is partially or completely removed by movement such as walking or stretching, at least as long as the activity continues, and
• the urge to move or unpleasant sensations are worse at night or in the evening than during the day or only occur at night.
supportive clinical features are not essential to make a diagnosis of RLS, but may be helpful where there is diagnostic uncertainty.
family history of the condition in one series, additional periodic leg movements during wakefulness or sleep (periodic leg movements are described as rhythmic big toe extension with ankle dorsiflexion and occasional knee or hip flexion) or improvement after starting a dopaminergic agent
INV
iron studies, urea, electrolytes and creatinine and a test for thyroid function.
secondary causes
common secondary cause of RLS is iron deficiency
Renal failure and hypothyroidism
Referral
fewer than four of the essential clinical criteria of the International Restless Legs Syndrome Study Group are present
concerns about the possibility of a comorbid sleep problem-Individuals with RLS often have periodic limb movements in sleep (PLMS)
Rx
treatment of primary RLS is pharmacological
Effective dopaminergic medications include levodopa-carbidopa and synthetic dopamine agonists
4 caterogies of medications used
in the treatment of RLS: dopaminergic agents, anticonvulsants, benzodiazepines and opiates.
medication of choice in Australia tends to be pramipexole
Other options such as gabapentin, long- acting benzodiazepines (i.e. clonazepam) and opiates are considered second line agents.
pramipexole
Pramipexole is generally well tolerated, with nausea being the most frequent side effect. The most important potential side effects of pramipexole (and all non-ergoline dopamine agonists) are impulse control disorders.
These may manifest as compulsive shopping, pathological gambling, hypersexuality or punding (repetitive purposeless actions) with a mean duration of treatment of 9.5 months prior to the onset of such an adverse effect.
Augmentation
A problem with the use of dopaminergic agents in the treatment of RLS is augmentation. Augmentation is defined as the usual daily onset of restless legs symptoms
>starting earlier than they did before treatment.
>Augmentation may also result in
>increased severity of symptoms,
>the spread of symptoms to other parts of the body
and
>reduced duration of relief from symptoms with treatment
Augmentation with pramipexole occurs on average after 8 months of treatment and is generally mild. These mild symptoms can typically be managed by giving the dose earlier in the day.39 When symptoms are more severe, the medication may need to be substituted for a non-dopaminergic agent for a month and then recommenced.
D) CIRCADIAN RHYTHM SLEEP DISORDER in a shift worker
Circadian rhythm is the ‘body clock’ that assists in maintaining the sleep/wake cycle
The normal circadian rhythm is slightly longer than 24 hours, and so to be kept in check we rely on ‘environmental time cues’, the most important of which is the light/dark cycle from the sun
Inv
Sleep diary- sleep diary is typically filled out for at least 7 days, and records meals, caffeine intake and exercise as well as bedtime, estimated time of getting to sleep and waking.
Seven-day actigraphy can be a useful adjunct to a sleep diary
Exclude-
Full blood examination, urea, electrolytes and creatinine, iron studies and a test for thyroid function are useful to look for the presence of anaemia, renal failure, iron deficiency and thyroid disorders.